Clinical Evaluation of Oral Curcumin in Prevention of Acute

Document Type : Original Article (s)

Authors

1 Assistant Professor, Department of Radiation Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Resident, Department of Radiation Oncology, School of Medicine And Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Acute radiation induced dermatitis, has a history as long as breast radiotherapy. Although new techniques have reduced the onset of dermatitis in breast radiotherapy patients, no standard protocol exists for its prophylaxis. This study has evaluated “Curcumin” for prophylaxis of radiation induced dermatitis.Methods: 40 breast radiotherapy candidates randomly put in two equal groups, received oral capsules (four 500 mg capsules, 3 times a day) filled with Curcumin or Placebo from 2 days before to the last day of radiotherapy 6 weeks course. Dermatitis degree recorded in weekly visits.Findings: A faster increasing in mean degree of dermatitis was seen in placebo group. The difference was statistically significant in last two weeks of radiotherapy. No considerable side effect was reported. Patients’ age, type of surgery, hormone receptor and HER2/neu status, did not affect curcumin group superiority in degree of radiation induced dermatitis.Conclusion: Oral curcumin is effective in prophylaxis of radiation induced dermatitis in breast cancer radiation.

Keywords

References

  1. Burstein HJ, Harris JR, Morrow M. Malignant tumors of the breast. In: DeVita VT, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 1606-45.
  2. Haffty BG, Perez CA, Perez CA. Early stage breast cancer. In: Halperin EC, Perez CA, Brady LW, Wazer DE, Freeman C, editors. Perez and Brady's principles and practice of radiation oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 1175-92.
  3. Khan FM. The physics of radiation therapy. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2003.
  4. Hendee WR, Ibbott GS, Hendee EG. Radiation therapy physics. 3rd ed. New York: J. Wiley; 2005. p. 44-112.
  5. Khan FM. Treatment planning in radiation oncology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
  6. Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, et al. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 1996; 36(2): 345-9.
  7. Richardson J, Smith JE, McIntyre M, Thomas R, Pilkington K. Aloe vera for preventing radiation-induced skin reactions: a systematic literature review. Clin Oncol (R Coll Radiol) 2005; 17(6): 478-84.
  8. Fisher J, Scott C, Stevens R, Marconi B, Champion L, Freedman GM, et al. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000; 48(5): 1307-10.
  9. Halperin EC, Gaspar L, George S, Darr D, Pinnell S. A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. CNS Cancer Consortium. Int J Radiat Oncol Biol Phys 1993; 26(3): 413-6.
  10. Hemati S, Nasiri Motlagh B, Esnaashari O, Sarvizadeh M, Akbari M, Tajvidi M, et al. Topical Silver Sulfadiazine for Prevention of Acute Dermatitis during Irradiation for Breast Cancer: ESMO; 2010.
  11. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 2005; 11(20): 7490-8.
  12. Claria J, Romano M. Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer. Curr Pharm Des 2005; 11(26): 3431-47.
  13. Mann JR, DuBois RN. Cyclooxygenase-2 and gastrointestinal cancer. Cancer J 2004; 10(3): 145-52.
  14. Prescott SM. Is cyclooxygenase-2 the alpha and the omega in cancer? J Clin Invest 2000; 105(11): 1511-3.
  15. Ramachandran C, You W. Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res Treat 1999; 54(3): 269-78.
  16. Ramachandran C, Fonseca HB, Jhabvala P, Escalon EA, Melnick SJ. Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Lett 2002; 184(1): 1-6.
  17. Samaha HS, Kelloff GJ, Steele V, Rao CV, Reddy BS. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 1997; 57(7): 1301-5.
  18. Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, et al. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 2006; 1091: 151-69.
  19. Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 2003; 171(7): 3863-71.
  20. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997; 9(2): 240-6.
  21. Xu J, Fu Y, Chen A. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 2003; 285(1): G20-G30.
  22. Korutla L, Cheung JY, Mendelsohn J, Kumar R. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 1995; 16(8): 1741-5.
  23. Korutla L, Kumar R. Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A43 cells. Biochim Biophys Acta 1994; 1224(3): 597-600.
  24. Ryan JL, Heckler CE, Pentland AP, Morrow GR. Potential plasma biomarkers predicting radiation dermatitis in breast cancer patients. J Clin Oncol 2010; 28(15): 9144.
  25. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31(5): 1341-6.
  26. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 2008; 267(1): 133-64.
Journal of Isfahan Medical School
Volume 29, Issue 152 - Serial Number 152
July and August 2011
Pages 1216-1223

Files

History

  • Receive Date: 20 June 2011
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics